Vaughan Nelson Investment Management L.P. Sells 715 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vaughan Nelson Investment Management L.P. reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,055 shares of the medical equipment provider’s stock after selling 715 shares during the quarter. Vaughan Nelson Investment Management L.P.’s holdings in Intuitive Surgical were worth $1,073,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. State Street Corp grew its position in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC grew its position in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Geode Capital Management LLC increased its stake in Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after acquiring an additional 143,440 shares during the last quarter. Fisher Asset Management LLC raised its holdings in shares of Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after acquiring an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. boosted its position in shares of Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Raymond James upped their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Citigroup upped their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Piper Sandler restated an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Finally, Mizuho upped their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $582.98 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a market cap of $207.65 billion, a P/E ratio of 90.95, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. The stock has a 50 day simple moving average of $554.85 and a two-hundred day simple moving average of $514.38.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,671 shares of company stock valued at $3,188,254 over the last quarter. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.